MMH-407

DRUG2 trials

Sponsors

Materia Medica Holding

Conditions

InfluenzaViral Respiratory Infection

Phase 3

Clinical Trial of Efficacy and Safety of ММН-407 in Acute Respiratory Viral Infection

CompletedNCT04244084

Materia Medica HoldingViral Respiratory Infection

Start: 2019-10-08End: 2020-04-09Updated: 2022-05-17

Clinical Trial of Efficacy and Safety of ММН-407 in the Treatment of Influenza in Outpatient Adults

SuspendedNCT04250311

Materia Medica HoldingInfluenza

Start: 2019-12-12End: 2024-12-31Target: 314Updated: 2023-08-18